MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ICCM — IceCure Medical Ltd. Ordinary Shares
NasdaqIceCure Medical Ltd. Ordinary Shares
$1.57
-0.12(-7.10%)
- O
- 1.73
- H
- 1.79
- L
- 1.55
- V
- 306.78K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ICCM
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
IndustryCommon Stock
SectorNot available
IPO DateNov 6, 2013
Employees66
Stock ExchangeNasdaq
Ticker SymbolICCM
Key Financial Statistics
| Market Cap | $7.28M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.55 - $33.00 |
| 52-Week Avg Volume | 861.0K |
| VWAP | $1.65 |
| Transactions | 1,375 |
| Total Recorded Bars | 1,281 days |